Bunge Global (BG) Proxy Filing summary

Executive summary

• 2024 marked significant strategic progress, including nearing completion of the Viterra combination and the acquisition of CJ Selecta, enhancing global agribusiness capabilities and market reach.

• The Board approved a $500 million share repurchase and returned nearly $1.5 billion to shareholders through repurchases and dividends.

• Key investments included new oilseed processing and specialty oils facilities, and a partnership with Repsol for renewable feedstocks.

• The company faced challenging market conditions, particularly weaker oilseed processing margins in South America and North America.

• Forward-looking risks include macroeconomic uncertainty, geopolitical challenges, trade disruptions, and biofuel policy changes.

Voting matters and shareholder proposals

• Shareholders are asked to approve financial statements, appropriation of accumulated loss, a $2.80 per share dividend in four installments, discharge of Board and management from liability, election of directors, reelection of Board Chair, and committee members.

• Advisory votes include say-on-pay for executive compensation, approval of Board and management compensation under Swiss law, the Swiss Compensation Report, and the Swiss Statutory Non-Financial Matter Report.

• Appointment of Deloitte as independent auditor for both U.S. and Swiss requirements, and election of the Swiss Statutory Independent Voting Representative.

Board of directors and corporate governance

• Board will expand to 12 members upon Viterra deal closing, with four new directors nominated by Glencore and CPP Investments.

• 92% of director nominees are independent; 42% are female; average tenure is 3 years.

• Board refreshment, diversity, and succession planning are emphasized, with robust director selection and evaluation processes.

• Shareholder rights include annual director elections, proxy access, single class of stock, and the ability for 5% holders to call special meetings.